Validation of the Achalasia Patient-Reported Outcomes Questionnaire.

John E PandolfinoDustin A CarlsonJosie McGarvaPeter J KahrilasMichael VaeziDavid A Katzka Tiffany H Taft

Published in: Alimentary pharmacology & therapeutics (2022)

The APRO is a reliable and valid measure of achalasia symptoms that addresses the limitations of existing questionnaires. Symptom anxiety and hypervigilance moderate the relationship between APRO and quality of life; 33% of patients with achalasia exhibit concerning patterns in symptom severity, anxiety and hypervigilance that may contribute to poorer outcomes.

Keyphrases

patient reported outcomes
sleep quality
patient reported
psychometric properties
cross sectional
depressive symptoms
type diabetes
physical activity
weight loss